The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Bristol-Myers Squibb Company’s current trading price is -27.51% away from its 52-week high, while its distance from the 52-week low is -0.42%. The stock’s price range for this period has been between $59.28 and $81.43 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 21.81 million for the day, a number notably higher than the average daily volume of 10.42 million over the last three months.
The stock price for Bristol-Myers Squibb Company (BMY) currently stands at $59.03. The stock experienced a substantial increase in the last session, hitting $59.825 after starting at $59.44. The stock’s lowest price was $58.86 before closing at $59.49.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Bristol-Myers Squibb Company’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $81.43 on 12/01/22 and a low of $59.28 for the same time frame on 09/15/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Bristol-Myers Squibb Company (BMY) has experienced a quarterly decline of -8.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 124.28B and boasts a workforce of 34300 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 63.80, with a change in price of -11.51. Similarly, Bristol-Myers Squibb Company recorded 9,803,636 in trading volume during the last 100 days, posting a change of -16.32%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for BMY stands at 1.18. Similarly, the long-term debt-to-equity ratio is also 1.08.
BMY Stock Stochastic Average
Bristol-Myers Squibb Company’s raw stochastic average for the past 50 days is presently 2.61%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 3.74%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 4.62% and 11.48%, respectively.
BMY Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -17.96%. However, over the past six months, we’ve seen a stronger performance of -12.03%. The price of BMY leaped by -3.12% over the last 30 days. And in the last five days, it has fallen by -2.94%.
